Human Immune System Variation during 1 Year.

Cell Reports
Tadepally LakshmikanthPetter Brodin

Abstract

The human immune system varies extensively between individuals, but variation within individuals over time has not been well characterized. Systems-level analyses allow for simultaneous quantification of many interacting immune system components and the inference of global regulatory principles. Here, we present a longitudinal, systems-level analysis in 99 healthy adults 50 to 65 years of age and sampled every third month for 1 year. We describe the structure of interindividual variation and characterize extreme phenotypes along a principal curve. From coordinated measurement fluctuations, we infer relationships between 115 immune cell populations and 750 plasma proteins constituting the blood immune system. While most individuals have stable immune systems, the degree of longitudinal variability is an individual feature. The most variable individuals, in the absence of overt infections, exhibited differences in markers of metabolic health suggestive of a possible link between metabolic and immunologic homeostatic regulation.

References

Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E SchutyserJ Van Damme
Mar 10, 2001·European Journal of Immunology·M VulcanoS Sozzani
Sep 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Helene B BernsteinJerome A Zack
Jul 12, 2011·Nature Immunology·Helder I NakayaBali Pulendran
Mar 21, 2013·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Rachel FinckSean C Bendall
Oct 25, 2013·Science Translational Medicine·Amir HorowitzCatherine A Blish
May 6, 2014·Frontiers in Neuroendocrinology·S T NgoP A McCombe
Dec 18, 2014·Genome Biology·Gilberto E FloresNoah Fierer
Jan 17, 2015·Cell·Jean-Laurent Casanova, Laurent Abel
Feb 15, 2015·Endocrine·Eva KlingbergOla Hammarsten
Feb 24, 2015·Cytokine·Dusanka S SkundricHarley Y Tse
May 13, 2015·Nature Communications·Xaquin Castro DopicoJohn A Todd
Feb 16, 2016·Nature Immunology·Edward J CarrAdrian Liston
Aug 31, 2016·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·M O VersteylenB L Kietselaer
Nov 8, 2016·Cell Reports·Raul Aguirre-GamboaHans J P M Koenen
Dec 6, 2016·Nature Reviews. Immunology·Petter Brodin, Mark M Davis
Apr 30, 2017·Genome Biology·Vasiliki MatzarakiAlexandra Zhernakova
Jul 12, 2017·Proceedings of the National Academy of Sciences of the United States of America·Kevin J KaczorowskiPetter Brodin
Dec 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Barbara PiaseckaUNKNOWN Milieu Intérieur Consortium
Jan 9, 2018·Nature Medicine·Carsten KriegBurkhard Becher
Feb 25, 2018·Nature Immunology·Etienne PatinUNKNOWN Milieu Intérieur Consortium
Mar 1, 2018·Annual Review of Immunology·Mark M Davis, Petter Brodin
Jul 27, 2018·Nature Reviews. Endocrinology·Claudio FranceschiAurelia Santoro
Aug 25, 2018·Cell·Axel OlinPetter Brodin
Jan 23, 2019·Methods in Molecular Biology·Tadepally Lakshmikanth, Petter Brodin
Feb 5, 2019·Cell Metabolism·Nicolas DamondBernd Bodenmiller
May 12, 2019·Methods in Molecular Biology·Jaromir MikesPetter Brodin
Jun 20, 2019·Immunity·Petter BrodinLluis Quintana-Murci

❮ Previous
Next ❯

Citations

Aug 23, 2020·Journal of Clinical Immunology·Lucie Rodriguez, Petter Brodin
Sep 10, 2020·Nature Communications·Abdellah TebaniLinn Fagerberg
May 5, 2021·Nature Communications·Wen ZhongMathias Uhlén

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.